SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3pg1'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FSL_B_NIOB145_1 (LEGHEMOGLOBIN A)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	4 / 8	PHE A 352 ILE A 79 LEU A 66 VAL A 75	None	0.83A	1fslB-3pg1A: undetectable	1fslB-3pg1A: 17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1G60_A_SAMA500_0 (ADENINE-SPECIFIC METHYLTRANSFERASE MBOIIA)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	CYH A 221 PHE A 233 GLY A 235 SER A 236 THR A 237	None	1.32A	1g60A-3pg1A: undetectable	1g60A-3pg1A: 19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NW5_A_SAMA401_1 (MODIFICATION METHYLASE RSRI)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	3 / 3	ASP A 118 HIS A 160 ASP A 176	None	0.76A	1nw5A-3pg1A: undetectable	1nw5A-3pg1A: 23.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PXX_A_DIFA701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 10	LEU A 300 GLY A 220 ALA A 219 SER A 218 LEU A 159	None	1.03A	1pxxA-3pg1A: undetectable	1pxxA-3pg1A: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PXX_C_DIFC2701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	LEU A 300 GLY A 220 ALA A 219 SER A 218 LEU A 159	None	1.03A	1pxxC-3pg1A: undetectable	1pxxC-3pg1A: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	6 / 12	ALA A 49 LEU A 82 LEU A 91 THR A 112 LEU A 149 HIS A 156	None	0.73A	1uwhA-3pg1A: 14.6	1uwhA-3pg1A: 24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_B_BAXB1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	6 / 12	ALA A 49 LEU A 82 LEU A 91 THR A 112 LEU A 149 HIS A 156	None	0.73A	1uwhB-3pg1A: 14.5	1uwhB-3pg1A: 24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ITZ_A_IREA2021_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	3 / 3	LEU A 110 LEU A 114 MET A 115	None	0.82A	2itzA-3pg1A: 20.4	2itzA-3pg1A: 24.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X2N_D_X2ND1479_1 (LANOSTEROL 14-ALPHA-DEMETHYLASE)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	ILE A 172 ALA A 278 ALA A 280 THR A 282 LEU A 293	None	1.36A	2x2nD-3pg1A: undetectable	2x2nD-3pg1A: 19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BBT_B_FMMB91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	7 / 12	ALA A 49 THR A 112 LEU A 114 LEU A 165 ASP A 176 PHE A 177 LEU A 179	None	0.96A	3bbtB-3pg1A: 19.8	3bbtB-3pg1A: 26.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE 4)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	GLU A 102 SER A 67 VAL A 345 TYR A 346 HIS A 106	None	1.40A	3bjmB-3pg1A: 3.1	3bjmB-3pg1A: 17.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BWM_A_SAMA301_0 (CATECHOL O-METHYLTRANSFERASE)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	MET A 115 VAL A 48 GLY A 92 ILE A 90 ASN A 89	None	1.33A	3bwmA-3pg1A: undetectable	3bwmA-3pg1A: 21.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	VAL A 37 ALA A 49 LEU A 82 THR A 112 HIS A 156	None	0.32A	3gcsA-3pg1A: 24.7	3gcsA-3pg1A: 36.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_2 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	4 / 7	LEU A 110 LEU A 114 MET A 115 ILE A 90	None	0.97A	3gp0A-3pg1A: 34.1	3gp0A-3pg1A: 38.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_2 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	4 / 7	LYS A 51 LEU A 114 MET A 115 ILE A 90	None	0.90A	3gp0A-3pg1A: 34.1	3gp0A-3pg1A: 38.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	ALA A 49 LEU A 81 LEU A 82 THR A 112 LEU A 114	None	0.60A	3hecA-3pg1A: 25.1	3hecA-3pg1A: 37.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	VAL A 37 ALA A 49 LYS A 51 LEU A 82 THR A 112	None	0.59A	3hegA-3pg1A: 33.2	3hegA-3pg1A: 37.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 8	ALA A 49 LYS A 51 LEU A 110 THR A 112 LEU A 114	None	0.37A	3lfaA-3pg1A: 33.9	3lfaA-3pg1A: 37.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M6V_B_SAMB465_0 (RRNA METHYLASE)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	GLY A 209 VAL A 257 ASP A 256 PRO A 201 LEU A 242	None	1.10A	3m6vB-3pg1A: undetectable	3m6vB-3pg1A: 21.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_1 (P38A)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	VAL A 37 ALA A 49 LYS A 51 LEU A 82 THR A 112	None	0.42A	3ohtB-3pg1A: 7.3	3ohtB-3pg1A: 35.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AC9_C_DXCC1476_0 (MJ0495-LIKE PROTEIN)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	4 / 5	ILE A 164 ALA A 219 HIS A 141 MET A 139	None	0.98A	4ac9B-3pg1A: undetectable 4ac9C-3pg1A: undetectable	4ac9B-3pg1A: 21.30 4ac9C-3pg1A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACA_C_DXCC1476_0 (TRANSLATION ELONGATION FACTOR SELB)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	4 / 5	ILE A 164 ALA A 219 HIS A 141 MET A 139	None	1.02A	4acaB-3pg1A: undetectable 4acaC-3pg1A: undetectable	4acaB-3pg1A: 21.30 4acaC-3pg1A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4COX_A_IMNA701_1 (CYCLOOXYGENASE-2)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	LEU A 300 GLY A 220 ALA A 219 SER A 218 LEU A 159	None	1.11A	4coxA-3pg1A: 0.9	4coxA-3pg1A: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4COX_B_IMNB701_1 (CYCLOOXYGENASE-2)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	LEU A 300 GLY A 220 ALA A 219 SER A 218 LEU A 159	None	1.12A	4coxB-3pg1A: undetectable	4coxB-3pg1A: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4COX_D_IMND701_1 (CYCLOOXYGENASE-2)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	LEU A 300 GLY A 220 ALA A 219 SER A 218 LEU A 159	None	1.11A	4coxD-3pg1A: undetectable	4coxD-3pg1A: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MA3_L_ACTL301_0 (C2095 HEAVY CHAIN C2095 LIGHT CHAIN)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	3 / 3	PRO A 88 ASN A 89 HIS A 141	None	1.02A	4ma3H-3pg1A: undetectable 4ma3L-3pg1A: undetectable	4ma3H-3pg1A: 18.63 4ma3L-3pg1A: 21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTY_A_LURA705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	LEU A 300 GLY A 220 ALA A 219 SER A 218 LEU A 159	None	1.10A	4otyA-3pg1A: undetectable	4otyA-3pg1A: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RRW_C_LURC705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	LEU A 300 GLY A 220 ALA A 219 SER A 218 LEU A 159	None	1.10A	4rrwC-3pg1A: undetectable	4rrwC-3pg1A: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RRZ_C_LURC705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	LEU A 300 GLY A 220 ALA A 219 SER A 218 LEU A 159	None	1.10A	4rrzC-3pg1A: undetectable	4rrzC-3pg1A: 21.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XOY_A_DX4A401_0 (MITOGEN-ACTIVATED PROTEIN KINASE 1)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	4 / 6	ALA A 49 LEU A 114 MET A 115 LEU A 165	None	0.78A	4xoyA-3pg1A: 11.8	4xoyA-3pg1A: 39.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XP3_A_DX4A401_0 (MITOGEN-ACTIVATED PROTEIN KINASE 1)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	4 / 6	ALA A 49 LEU A 114 MET A 115 LEU A 165	None	0.91A	4xp3A-3pg1A: 32.3	4xp3A-3pg1A: 39.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XUE_B_SAMB303_0 (CATECHOL O-METHYLTRANSFERASE)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	MET A 115 VAL A 48 GLY A 92 ILE A 90 ASN A 89	None	1.29A	4xueB-3pg1A: undetectable	4xueB-3pg1A: 21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HI2_A_BAXA801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	6 / 12	ALA A 49 LEU A 82 LEU A 91 THR A 112 LEU A 149 HIS A 156	None	0.72A	5hi2A-3pg1A: 6.1	5hi2A-3pg1A: 25.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I3C_B_AC2B301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 10	GLY A 145 ALA A 152 VAL A 148 GLU A 151 ILE A 90	None	1.06A	5i3cB-3pg1A: undetectable	5i3cB-3pg1A: 21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I3C_C_AC2C301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 11	GLY A 145 ALA A 152 VAL A 148 GLU A 151 ILE A 90	None	1.20A	5i3cC-3pg1A: undetectable	5i3cC-3pg1A: 21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IKQ_A_JMSA602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	3pg1	MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN) (Leishmania major)	5 / 12	LEU A 300 GLY A 220 ALA A 219 SER A 218 LEU A 159	None	1.04A	5ikqA-3pg1A: undetectable	5ikqA-3pg1A: 20.18

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FSL_B_NIOB145_1","LEGHEMOGLOBIN A","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",4,"PHE A 352;ILE A  79;LEU A  66;VAL A  75","None","0.83A","1fslB-3pg1A:undetectable","1fslB-3pg1A:17.18"],["1G60_A_SAMA500_0","ADENINE-SPECIFIC METHYLTRANSFERASE MBOIIA","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"CYH A 221;PHE A 233;GLY A 235;SER A 236;THR A 237","None","1.32A","1g60A-3pg1A:undetectable","1g60A-3pg1A:19.68"],["1NW5_A_SAMA401_1","MODIFICATION METHYLASE RSRI","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",3,"ASP A 118;HIS A 160;ASP A 176","None","0.76A","1nw5A-3pg1A:undetectable","1nw5A-3pg1A:23.86"],["1PXX_A_DIFA701_1","PROSTAGLANDIN G\/H SYNTHASE 2","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"LEU A 300;GLY A 220;ALA A 219;SER A 218;LEU A 159","None","1.03A","1pxxA-3pg1A:undetectable","1pxxA-3pg1A:20.20"],["1PXX_C_DIFC2701_1","PROSTAGLANDIN G\/H SYNTHASE 2","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"LEU A 300;GLY A 220;ALA A 219;SER A 218;LEU A 159","None","1.03A","1pxxC-3pg1A:undetectable","1pxxC-3pg1A:20.20"],["1UWH_A_BAXA1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",6,"ALA A  49;LEU A  82;LEU A  91;THR A 112;LEU A 149;HIS A 156","None","0.73A","1uwhA-3pg1A:14.6","1uwhA-3pg1A:24.93"],["1UWH_B_BAXB1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",6,"ALA A  49;LEU A  82;LEU A  91;THR A 112;LEU A 149;HIS A 156","None","0.73A","1uwhB-3pg1A:14.5","1uwhB-3pg1A:24.93"],["2ITZ_A_IREA2021_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",3,"LEU A 110;LEU A 114;MET A 115","None","0.82A","2itzA-3pg1A:20.4","2itzA-3pg1A:24.68"],["2X2N_D_X2ND1479_1","LANOSTEROL 14-ALPHA-DEMETHYLASE","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"ILE A 172;ALA A 278;ALA A 280;THR A 282;LEU A 293","None","1.36A","2x2nD-3pg1A:undetectable","2x2nD-3pg1A:19.92"],["3BBT_B_FMMB91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",7,"ALA A  49;THR A 112;LEU A 114;LEU A 165;ASP A 176;PHE A 177;LEU A 179","None","0.96A","3bbtB-3pg1A:19.8","3bbtB-3pg1A:26.85"],["3BJM_B_BJMB2_1","DIPEPTIDYL PEPTIDASE 4","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"GLU A 102;SER A  67;VAL A 345;TYR A 346;HIS A 106","None","1.40A","3bjmB-3pg1A:3.1","3bjmB-3pg1A:17.61"],["3BWM_A_SAMA301_0","CATECHOL O-METHYLTRANSFERASE","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"MET A 115;VAL A  48;GLY A  92;ILE A  90;ASN A  89","None","1.33A","3bwmA-3pg1A:undetectable","3bwmA-3pg1A:21.72"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"VAL A  37;ALA A  49;LEU A  82;THR A 112;HIS A 156","None","0.32A","3gcsA-3pg1A:24.7","3gcsA-3pg1A:36.01"],["3GP0_A_NILA1_2","MITOGEN-ACTIVATED PROTEIN KINASE 11","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",4,"LEU A 110;LEU A 114;MET A 115;ILE A  90","None","0.97A","3gp0A-3pg1A:34.1","3gp0A-3pg1A:38.32"],["3GP0_A_NILA1_2","MITOGEN-ACTIVATED PROTEIN KINASE 11","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",4,"LYS A  51;LEU A 114;MET A 115;ILE A  90","None","0.90A","3gp0A-3pg1A:34.1","3gp0A-3pg1A:38.32"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"ALA A  49;LEU A  81;LEU A  82;THR A 112;LEU A 114","None","0.60A","3hecA-3pg1A:25.1","3hecA-3pg1A:37.00"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"VAL A  37;ALA A  49;LYS A  51;LEU A  82;THR A 112","None","0.59A","3hegA-3pg1A:33.2","3hegA-3pg1A:37.00"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"ALA A  49;LYS A  51;LEU A 110;THR A 112;LEU A 114","None","0.37A","3lfaA-3pg1A:33.9","3lfaA-3pg1A:37.14"],["3M6V_B_SAMB465_0","RRNA METHYLASE","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"GLY A 209;VAL A 257;ASP A 256;PRO A 201;LEU A 242","None","1.10A","3m6vB-3pg1A:undetectable","3m6vB-3pg1A:21.30"],["3OHT_B_1N1B1000_1","P38A","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"VAL A  37;ALA A  49;LYS A  51;LEU A  82;THR A 112","None","0.42A","3ohtB-3pg1A:7.3","3ohtB-3pg1A:35.22"],["4AC9_C_DXCC1476_0","MJ0495-LIKE PROTEIN","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",4,"ILE A 164;ALA A 219;HIS A 141;MET A 139","None","0.98A","4ac9B-3pg1A:undetectable;4ac9C-3pg1A:undetectable","4ac9B-3pg1A:21.30;4ac9C-3pg1A:21.30"],["4ACA_C_DXCC1476_0","TRANSLATION ELONGATION FACTOR SELB","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",4,"ILE A 164;ALA A 219;HIS A 141;MET A 139","None","1.02A","4acaB-3pg1A:undetectable;4acaC-3pg1A:undetectable","4acaB-3pg1A:21.30;4acaC-3pg1A:21.30"],["4COX_A_IMNA701_1","CYCLOOXYGENASE-2","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"LEU A 300;GLY A 220;ALA A 219;SER A 218;LEU A 159","None","1.11A","4coxA-3pg1A:0.9","4coxA-3pg1A:21.64"],["4COX_B_IMNB701_1","CYCLOOXYGENASE-2","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"LEU A 300;GLY A 220;ALA A 219;SER A 218;LEU A 159","None","1.12A","4coxB-3pg1A:undetectable","4coxB-3pg1A:21.64"],["4COX_D_IMND701_1","CYCLOOXYGENASE-2","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"LEU A 300;GLY A 220;ALA A 219;SER A 218;LEU A 159","None","1.11A","4coxD-3pg1A:undetectable","4coxD-3pg1A:21.64"],["4MA3_L_ACTL301_0","C2095 HEAVY CHAIN;C2095 LIGHT CHAIN","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",3,"PRO A  88;ASN A  89;HIS A 141","None","1.02A","4ma3H-3pg1A:undetectable;4ma3L-3pg1A:undetectable","4ma3H-3pg1A:18.63;4ma3L-3pg1A:21.75"],["4OTY_A_LURA705_1","PROSTAGLANDIN G\/H SYNTHASE 2","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"LEU A 300;GLY A 220;ALA A 219;SER A 218;LEU A 159","None","1.10A","4otyA-3pg1A:undetectable","4otyA-3pg1A:21.64"],["4RRW_C_LURC705_1","PROSTAGLANDIN G\/H SYNTHASE 2","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"LEU A 300;GLY A 220;ALA A 219;SER A 218;LEU A 159","None","1.10A","4rrwC-3pg1A:undetectable","4rrwC-3pg1A:21.64"],["4RRZ_C_LURC705_1","PROSTAGLANDIN G\/H SYNTHASE 2","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"LEU A 300;GLY A 220;ALA A 219;SER A 218;LEU A 159","None","1.10A","4rrzC-3pg1A:undetectable","4rrzC-3pg1A:21.64"],["4XOY_A_DX4A401_0","MITOGEN-ACTIVATED PROTEIN KINASE 1","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",4,"ALA A  49;LEU A 114;MET A 115;LEU A 165","None","0.78A","4xoyA-3pg1A:11.8","4xoyA-3pg1A:39.36"],["4XP3_A_DX4A401_0","MITOGEN-ACTIVATED PROTEIN KINASE 1","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",4,"ALA A  49;LEU A 114;MET A 115;LEU A 165","None","0.91A","4xp3A-3pg1A:32.3","4xp3A-3pg1A:39.36"],["4XUE_B_SAMB303_0","CATECHOL O-METHYLTRANSFERASE","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"MET A 115;VAL A  48;GLY A  92;ILE A  90;ASN A  89","None","1.29A","4xueB-3pg1A:undetectable","4xueB-3pg1A:21.45"],["5HI2_A_BAXA801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",6,"ALA A  49;LEU A  82;LEU A  91;THR A 112;LEU A 149;HIS A 156","None","0.72A","5hi2A-3pg1A:6.1","5hi2A-3pg1A:25.73"],["5I3C_B_AC2B301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"GLY A 145;ALA A 152;VAL A 148;GLU A 151;ILE A  90","None","1.06A","5i3cB-3pg1A:undetectable","5i3cB-3pg1A:21.57"],["5I3C_C_AC2C301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"GLY A 145;ALA A 152;VAL A 148;GLU A 151;ILE A  90","None","1.20A","5i3cC-3pg1A:undetectable","5i3cC-3pg1A:21.57"],["5IKQ_A_JMSA602_1","PROSTAGLANDIN G\/H SYNTHASE 2","3pg1","MITOGEN-ACTIVATED PROTEIN KINASE, PUTATIVE (MAP KINASE-LIKE PROTEIN)","Leishmania major",5,"LEU A 300;GLY A 220;ALA A 219;SER A 218;LEU A 159","None","1.04A","5ikqA-3pg1A:undetectable","5ikqA-3pg1A:20.18"]]